Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2206
https://www.valueinhealthjournal.com/article/S1098-3015(16)33572-0/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2096
First Page :
A732
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33572-0&doi=10.1016/j.jval.2016.09.2206